Literature evidence suggests that the over-expression of MMP-2 is an active contributor to the progression of malignant GB [29,30,31] and NB [32,33,34] via increased cancer-cell growth, migration, invasion, and angiogenesis. This evidence concerns the gene MMP2 and neuroblastoma.